We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Maggots Quickly Clear Chronic Leg Ulcers

By HospiMedica International staff writers
Posted on 05 Jan 2012
A new study has found that just one week of maggot debridement therapy (MDT) clears necrotic tissue more effectively than conventional debridement in patients with chronic venous ulcers.

Researchers at the Centre Hospitalier Universitaire (Caen, France) conducted a prospective study involving 119 hospitalized patients (mean age 73) with a nonhealing, sloughy lower-leg ulcers 40 cm2 or smaller, less than 2 cm deep, and an ankle brachial index of 0.8 or higher. More...
Twice-weekly maggot therapy was administered in a polyvinyl alcohol membrane bag containing 80 sterile Lucilia sericata maggots that were able to access wound surfaces through the bag; control patients had surgical debridement under topical anesthesia three times each week. All patients wore blindfolds during the treatment, and were unaware of the difference in treatment schedules. The main outcome measure was percentage of slough in wounds at day 15.

The results showed that there was a significant difference between groups at day 8 (54.5% in the MDT group and 66.5% in the control group), but there was no difference between the groups in percentage of the necrotic tissue on the wound at day 15 (55.4% versus 53.8%). In fact, the wound surface area had increased by 14.6% in patients receiving maggot therapy and had decreased by 8.2% among patients treated with surgical debridement, suggesting that a second week of maggot therapy could be deleterious. The study was published early online on December 19, 2011, in Archives of Dermatology.

“Contrary to surgical debridement, maggot therapy is easy, safe, painless, and well accepted by the patient,” concluded lead author Anne Dompmartin, MD, PhD, and colleagues of the department of dermatology. “There is no benefit in continuing the treatment after one week, and maggot therapy does not improve the time to wound closure, which is why it should be stopped when debridement is achieved.”

MDT, also known as larval therapy, biodebridement, or biosurgery, involves the intentional introduction of live, disinfected maggots (fly larvae) into the nonhealing skin and soft tissue wounds for the purpose of debriding the necrotic tissue within the wound. The maggots are contained in a cage-like dressing or a sealed pouch, with the wound floor acting as the bottom of the cage or pouch. When the maggots are satiated, they become substantially larger and seek to leave the site of a wound. Multiple two-day courses of maggot therapy may be administered depending on the severity of the non-healing wound.

Related Links:
Centre Hospitalier Universitaire


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Anesthesia Cart
UTGSU-333369-DKB
New
Mobile X-Ray Machine
MARS 15 / 30
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.